Press release – For immediate release – 5:45pm CEST
- Median Technologies will showcase its iBiopsy® platform for liver diseases at booth #241.
- The Imaging Phenomics Company® is now a registered trademark of Median Technologies.
Median Technologies, the Imaging Phenomics Company®, announced today that it will participate in The Liver Meeting®, the annual meeting of the Association for the Study of Liver Diseases (AASLD) October 20-24 at the Walter E. Washington Convention Center, Washington DC, USA. The industry exhibition will be opened from Oct 21st to Oct. 23rd. The company’s scientific and business team will demonstrate Median’s imaging phenomics platform iBiopsy® at booth #241.
iBiopsy® is Median’s investigational platform designed to acquire, index, and analyze imaging phenomics, decoding disease biomarkers from standard medical images. iBiopsy® is at the core of precision and predictive medicine, providing insights into the development of novel therapies and individualized treatment strategies. The first application of iBiopsy® is for the assessment of Nonalcoholic Steatohepatitis (NASH), a liver disease which is dramatically increasing in prevalence in all parts of the world.
iBiopsy® is also the backbone of Median’s innovative development efforts and combines the latest advances in artificial intelligence (AI) and big data predictive analytics to harness the power of imaging phenomics. Because of its leading role within the field of imaging phenomics, Median Technologies is proud to announce that “The Imaging Phenomics Company®” is now a registered trademark of Median Technologies.
The Liver Meeting® is organized every year by the American Association for the Study of Liver Diseases (AASLD) and is the premier conference in the science and practice of hepatology, including the latest findings on new drugs, novel treatments, and the results from pilot and multicenter studies. More information about The Liver Meeting® is here: https://www.aasld.org/events-professional-development/liver-meeting.
The Liver Meeting® is a registered trademark of the American Association for the Study of Liver Diseases.